Search research articles
Contact Us
Filters
Showing results (161-170 of 457) with videos related to
Page
of 46
Sort By:
American Journal of Hematology
|
September 4, 2025
Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High-Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTX
Khalil Hassan, Anmol Baranwal, Al Rabee Kassis, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 20, 2016
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia
Mehrdad Hefazi, Moussab Damlaj, Hassan B Alkhateeb, et al.
Leukemia Research
|
July 3, 2014
Younger adults with acute myeloid leukemia in remission for ≥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patients
Justin M Watts, Xin Victoria Wang, Mark R Litzow, et al.
Leukemia Research
|
July 18, 2018
Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts
Abhishek A Mangaonkar, Naseema Gangat, Aref Al-Kali, et al.
Bone Marrow Transplantation
|
April 5, 2025
Outcomes of attenuated dose fludarabine and melphalan based conditioning regimen in patients undergoing allogeneic stem cell transplant: a propensity score-matched analysis
Anmol Baranwal, Rabee Kassis, Khalil Hassan, et al.
Haematologica
|
July 2, 2026
Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series
Ashya R Burgess, Husnain Ali, Jabra Zarka, et al.
Mayo Clinic Proceedings
|
August 6, 2019
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
Aref Al-Kali, Darci Zblewski, James M Foran, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 14, 2015
Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey
Eun-Ju Lee, B Douglas Smith, Jessica W Merrey, et al.
British Journal of Haematology
|
May 26, 2022
Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real-world experience
Naseema Gangat, Kristen McCullough, Aref Al-Kali, et al.
Blood Advances
|
March 31, 2022
Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents
Isla M Johnson, Evandro D Bezerra, Faiqa Farrukh, et al.
Page
of 46
Search research articles
Search
Showing results (161-170 of 457) with videos related to
Sort By:
Page
of 46
American Journal of Hematology
|
September 4, 2025
Risk of Relapse Post Reduced Intensity Conditioning Allogeneic Stem Cell Transplant in Patients With High-Risk Myeloid Neoplasms Based on GvHD Prophylaxis: PTCy Vs. TAC/MTX
Khalil Hassan, Anmol Baranwal, Al Rabee Kassis, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 20, 2016
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia
Mehrdad Hefazi, Moussab Damlaj, Hassan B Alkhateeb, et al.
Leukemia Research
|
July 3, 2014
Younger adults with acute myeloid leukemia in remission for ≥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patients
Justin M Watts, Xin Victoria Wang, Mark R Litzow, et al.
Leukemia Research
|
July 18, 2018
Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts
Abhishek A Mangaonkar, Naseema Gangat, Aref Al-Kali, et al.
Bone Marrow Transplantation
|
April 5, 2025
Outcomes of attenuated dose fludarabine and melphalan based conditioning regimen in patients undergoing allogeneic stem cell transplant: a propensity score-matched analysis
Anmol Baranwal, Rabee Kassis, Khalil Hassan, et al.
Haematologica
|
July 2, 2026
Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series
Ashya R Burgess, Husnain Ali, Jabra Zarka, et al.
Mayo Clinic Proceedings
|
August 6, 2019
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
Aref Al-Kali, Darci Zblewski, James M Foran, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 14, 2015
Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey
Eun-Ju Lee, B Douglas Smith, Jessica W Merrey, et al.
British Journal of Haematology
|
May 26, 2022
Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real-world experience
Naseema Gangat, Kristen McCullough, Aref Al-Kali, et al.
Blood Advances
|
March 31, 2022
Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents
Isla M Johnson, Evandro D Bezerra, Faiqa Farrukh, et al.
Page
of 46